The TEBRIVAN brand, founded in 2007 (United States), from 18 sister brands and 2214 competing brands. The TEBRIVAN brand is owned by Vertex Pharma, a company listed in New York. TEBRIVAN is part of the Biotechnology activity sector.
Investment simulator :
Portfolio valuation
Vertex Pharma
(TEBRIVAN)
over 5 years*
USD 920.97